These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34093394)

  • 1. Novel Optineurin Frameshift Insertion in a Family With Frontotemporal Dementia and Parkinsonism Without Amyotrophic Lateral Sclerosis.
    Dominguez J; Yu JT; Tan YJ; Ng A; De Guzman MF; Natividad B; Daroy ML; Cano J; Yu J; Lian MM; Zeng L; Lim WK; Foo JN; Ng ASL
    Front Neurol; 2021; 12():645913. PubMed ID: 34093394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease.
    Pottier C; Bieniek KF; Finch N; van de Vorst M; Baker M; Perkersen R; Brown P; Ravenscroft T; van Blitterswijk M; Nicholson AM; DeTure M; Knopman DS; Josephs KA; Parisi JE; Petersen RC; Boylan KB; Boeve BF; Graff-Radford NR; Veltman JA; Gilissen C; Murray ME; Dickson DW; Rademakers R
    Acta Neuropathol; 2015 Jul; 130(1):77-92. PubMed ID: 25943890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrafamilial phenotypic heterogeneity in a Taiwanese family with a MAPT p.R5H mutation: a case report and literature review.
    Lin HC; Lin CH; Chen PL; Cheng SJ; Chen PH
    BMC Neurol; 2017 Sep; 17(1):186. PubMed ID: 28923025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in the prevalence of genetic mutations in FTD and ALS: A meta-analysis.
    Curtis AF; Masellis M; Hsiung GR; Moineddin R; Zhang K; Au B; Millett G; Mackenzie I; Rogaeva E; Tierney MC
    Neurology; 2017 Oct; 89(15):1633-1642. PubMed ID: 28916533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OPTN p.Met468Arg and ATXN2 intermediate length polyQ extension in families with C9orf72 mediated amyotrophic lateral sclerosis and frontotemporal dementia.
    Farhan SMK; Gendron TF; Petrucelli L; Hegele RA; Strong MJ
    Am J Med Genet B Neuropsychiatr Genet; 2018 Jan; 177(1):75-85. PubMed ID: 29080331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing.
    Le Ber I; Camuzat A; Guillot-Noel L; Hannequin D; Lacomblez L; Golfier V; Puel M; Martinaud O; Deramecourt V; Rivaud-Pechoux S; Millecamps S; Vercelletto M; Couratier P; Sellal F; Pasquier F; Salachas F; Thomas-Antérion C; Didic M; Pariente J; Seilhean D; Ruberg M; Wargon I; Blanc F; Camu W; Michel BF; Berger E; Sauvée M; Thauvin-Robinet C; Mondon K; Tournier-Lasserve E; Goizet C; Fleury M; Viennet G; Verpillat P; Meininger V; Duyckaerts C; Dubois B; Brice A
    J Alzheimers Dis; 2013; 34(2):485-99. PubMed ID: 23254636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on genetic frontotemporal dementia.
    Greaves CV; Rohrer JD
    J Neurol; 2019 Aug; 266(8):2075-2086. PubMed ID: 31119452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mutation in optineurin causing aggressive ALS+/-frontotemporal dementia.
    Feng SM; Che CH; Feng SY; Liu CY; Li LY; Li YX; Huang HP; Zou ZY
    Ann Clin Transl Neurol; 2019 Dec; 6(12):2377-2383. PubMed ID: 31838784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinsonian syndrome in familial frontotemporal dementia.
    Siuda J; Fujioka S; Wszolek ZK
    Parkinsonism Relat Disord; 2014 Sep; 20(9):957-64. PubMed ID: 24998994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C9orf72 expansions are the most common cause of genetic frontotemporal dementia in a Southeast Asian cohort.
    Tan YJ; Yong ACW; Foo JN; Lian MM; Lim WK; Dominguez J; Fong ZH; Narasimhalu K; Chiew HJ; Ng KP; Ting SKS; Kandiah N; Ng ASL
    Ann Clin Transl Neurol; 2023 Apr; 10(4):568-578. PubMed ID: 36799407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The First Historically Reported Italian Family with FTD/ALS Teaches a Lesson on C9orf72 RE: Clinical Heterogeneity and Oligogenic Inheritance.
    Giannoccaro MP; Bartoletti-Stella A; Piras S; Casalena A; Oppi F; Ambrosetto G; Montagna P; Liguori R; Parchi P; Capellari S
    J Alzheimers Dis; 2018; 62(2):687-697. PubMed ID: 29480190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population.
    Cannas A; Solla P; Borghero G; Floris GL; Chio A; Mascia MM; Modugno N; Muroni A; Orofino G; Di Stefano F; Calvo A; Moglia C; Restagno G; Meloni M; Farris R; Ciaccio D; Puddu R; Vacca MI; Melis R; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Marrosu MG; Marrosu F
    J Neurol; 2015 Nov; 262(11):2498-503. PubMed ID: 26275564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotyping and Plasma/Cerebrospinal Fluid Profiling of a Cohort of Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Patients.
    Bourbouli M; Paraskevas GP; Rentzos M; Mathioudakis L; Zouvelou V; Bougea A; Tychalas A; Kimiskidis VK; Constantinides V; Zafeiris S; Tzagournissakis M; Papadimas G; Karadima G; Koutsis G; Kroupis C; Kartanou C; Kapaki E; Zaganas I
    Brain Sci; 2021 Sep; 11(9):. PubMed ID: 34573259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical spectrum of sporadic and familial forms of frontotemporal dementia.
    Woollacott IO; Rohrer JD
    J Neurochem; 2016 Aug; 138 Suppl 1():6-31. PubMed ID: 27144467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the
    Dols-Icardo O; García-Redondo A; Rojas-García R; Borrego-Hernández D; Illán-Gala I; Muñoz-Blanco JL; Rábano A; Cervera-Carles L; Juárez-Rufián A; Spataro N; De Luna N; Galán L; Cortes-Vicente E; Fortea J; Blesa R; Grau-Rivera O; Lleó A; Esteban-Pérez J; Gelpi E; Clarimón J
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):162-168. PubMed ID: 28889094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of compound heterozygous variants in OPTN in an ALS-FTD patient from the CReATe consortium: a case report.
    Pottier C; Rampersaud E; Baker M; Wu G; Wuu J; McCauley JL; Zuchner S; Schule R; Bermudez C; Hussain S; Cooley A; Wallace M; Zhang J; Taylor JP; Benatar M; Rademakers R
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):469-471. PubMed ID: 29558868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of Immune Activation by
    Trageser KJ; Smith C; Herman FJ; Ono K; Pasinetti GM
    Front Neurosci; 2019; 13():1298. PubMed ID: 31920478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature.
    Giannoccaro MP; Bartoletti-Stella A; Piras S; Pession A; De Massis P; Oppi F; Stanzani-Maserati M; Pasini E; Baiardi S; Avoni P; Parchi P; Liguori R; Capellari S
    J Neurol; 2017 Jul; 264(7):1426-1433. PubMed ID: 28620717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)].
    Tomiyama H
    Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.